Due to the limited effect of a PD-1 inhibitor in pancreatic cancer, it is shown that CXC chemokine receptor 4 (CXCR4) blockade promotes T cell infiltration with its synergistic effect with PD-1 inhibitors in mouse models [67,191]. The gene discussed is CXCR4; the disease is familial pancreatic carcinoma.